"This risk is exacerbated by the fact that there is currently no proven, widely accepted standard to determine marijuana ...

Drugs for inflammatory conditions drove nearly half of spending in commercial plans last year, a new report shows. Express Scripts released its annual Drug Trend Report, which analyzes costs and ...

Eliminating the protected classes of medications for Medicare Part D plans could give insurers more leverage to negotiate rebates, but may have a limited financial payoff, according to a new analysis.

This study analyzes 20 years of data from the Food and Drug Administration’s Adverse Event Reporting System (FAERS) to reveal ...

Turning the tide on antibiotic resistance will require new ways of working, writes executive director of the Global ...

A study from the University of Maryland, Baltimore County (UMBC), published in Nature Communications, reveals how ...

Individuals with HIV who were resistant to all four antiretroviral drug classes experienced higher mortality than those who were not resistant, a difference primarily due to lower CD4 cell counts.

The federal government has backed off a proposal that would have let Medicare Part D prescription drug plans deny coverage for therapies in six "protected" classes of drugs, including those for cancer ...

Scientists have identified two molecules that could help treat leukemia, in a way that’s far less damaging to healthy cells than existing chemotherapy. The compounds work using a different mechanism ...

PORTLAND, Ore. (KATU) — A new law increasing penalties on public transit took effect on Jan. 1. Senate Bill 1553 classifies the use of illicit drugs onboard public transit vehicles as a Class A ...

Doctors and researchers try to understand what medications a person has taken by asking patients directly or by looking at ...